{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:45:54Z","timestamp":1792784754923,"version":"4.5.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Wroclaw University of Technology and Foundation for Polish Science","id":[{"id":"https:\/\/ror.org\/048zd9m77","id-type":"ROR","asserted-by":"crossref"}]},{"name":"German Center for Infection Research (DZIF)","id":[{"id":"https:\/\/ror.org\/028s4q594","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.antiviral.2016.12.018","type":"journal-article","created":{"date-parts":[[2016,12,26]],"date-time":"2016-12-26T13:16:02Z","timestamp":1482758162000},"page":"88-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Extended substrate specificity and first potent irreversible inhibitor\/activity-based probe design for Zika virus NS2B-NS3 protease"],"prefix":"10.1016","volume":"139","author":[{"given":"Wioletta","family":"Rut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Kasperkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Poreba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Hilgenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Dr\u0105g","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.antiviral.2016.12.018_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","article-title":"Zika virus .1. Isolations and serological specificity","volume":"46","author":"Dick","year":"1952","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"10038","key":"10.1016\/j.antiviral.2016.12.018_bib2","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/S0140-6736(16)30773-5","article-title":"Association between Guillain-Barre syndrome and Zika virus infection reply","volume":"387","author":"Fontanet","year":"2016","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.antiviral.2016.12.018_bib3","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1002\/1873-3468.12443","article-title":"Substrate profiling of Zika virus NS2B-NS3 protease","volume":"590","author":"Gruba","year":"2016","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.antiviral.2016.12.018_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/cmdc.201200497","article-title":"Development and characterization of new peptidomimetic inhibitors of the West Nile virus NS2B-NS3 protease","volume":"8","author":"Hammamy","year":"2013","journal-title":"ChemMedChem"},{"issue":"7","key":"10.1016\/j.antiviral.2016.12.018_bib5","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1073\/pnas.1318548111","article-title":"Design of ultrasensitive probes for human neutrophil elastase through hybrid combinatorial substrate library profiling","volume":"111","author":"Kasperkiewicz","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.antiviral.2016.12.018_bib6","doi-asserted-by":"crossref","first-page":"e0132818","DOI":"10.1371\/journal.pone.0132818","article-title":"Design of a selective substrate and activity based probe for human neutrophil serine protease 4","volume":"10","author":"Kasperkiewicz","year":"2015","journal-title":"PLoS One"},{"issue":"6298","key":"10.1016\/j.antiviral.2016.12.018_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1126\/science.aag2419","article-title":"Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor","volume":"353","author":"Lei","year":"2016","journal-title":"Science"},{"issue":"49","key":"10.1016\/j.antiviral.2016.12.018_bib8","doi-asserted-by":"crossref","first-page":"45762","DOI":"10.1074\/jbc.M107360200","article-title":"Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors","volume":"276","author":"Leung","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"issue":"31","key":"10.1016\/j.antiviral.2016.12.018_bib9","doi-asserted-by":"crossref","first-page":"28766","DOI":"10.1074\/jbc.M500588200","article-title":"Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries","volume":"280","author":"Li","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.12.018_bib10","article-title":"Molecular Biology of Flaviviruses","volume":"vol. 59","author":"Lindenbach","year":"2003"},{"issue":"9","key":"10.1016\/j.antiviral.2016.12.018_bib11","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/cdd.2014.64","article-title":"Unnatural amino acids increase sensitivity and provide for the design of highly selective caspase substrates","volume":"21","author":"Poreba","year":"2014","journal-title":"Cell Death Differ."},{"issue":"8","key":"10.1016\/j.antiviral.2016.12.018_bib12","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.chembiol.2016.05.020","article-title":"Counter selection substrate library strategy for developing specific protease substrates and probes","volume":"23","author":"Poreba","year":"2016","journal-title":"Cell Chem. Biol."},{"issue":"20","key":"10.1016\/j.antiviral.2016.12.018_bib13","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMsr1604338","article-title":"Zika virus and birth defects - reviewing the evidence for causality","volume":"374","author":"Rasmussen","year":"2016","journal-title":"N.\u00a0Engl. J. Med."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216307173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216307173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T11:22:15Z","timestamp":1536146535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216307173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":13,"alternative-id":["S0166354216307173"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.12.018","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extended substrate specificity and first potent irreversible inhibitor\/activity-based probe design for Zika virus NS2B-NS3 protease","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}